ENHOPMA Trademark

Trademark Overview


On Monday, March 6, 2023, a trademark application was filed for ENHOPMA with the United States Patent and Trademark Office. The USPTO has given the ENHOPMA trademark a serial number of 79366725. The federal status of this trademark filing is REGISTERED as of Tuesday, June 4, 2024. This trademark is owned by CELLTRION, INC.. The ENHOPMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain, of COVID-19, and anti-interleukin-6 (il-6) receptor monoclonal antibody for the treatment of disease caused by il-6 production; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for suppressing cytokine; pharmaceutical preparations for the treatment of arteritis; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for immunity adjustment; monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases
enhopma

General Information


Serial Number79366725
Word MarkENHOPMA
Filing DateMonday, March 6, 2023
Status700 - REGISTERED
Status DateTuesday, June 4, 2024
Registration Number7404208
Registration DateTuesday, June 4, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of pain, of COVID-19, and anti-interleukin-6 (il-6) receptor monoclonal antibody for the treatment of disease caused by il-6 production; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for suppressing cytokine; pharmaceutical preparations for the treatment of arteritis; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for immunity adjustment; monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCELLTRION, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameCELLTRION, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameCELLTRION, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, April 6, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 11, 2023APPLICATION FILING RECEIPT MAILED
Monday, December 4, 2023ASSIGNED TO EXAMINER
Tuesday, January 2, 2024REFUSAL PROCESSED BY IB
Tuesday, December 5, 2023NON-FINAL ACTION WRITTEN
Wednesday, December 6, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 13, 2023REFUSAL PROCESSED BY MPU
Wednesday, December 13, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 23, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 31, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 2, 2024WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 4, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, September 4, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, November 16, 2024FINAL DISPOSITION PROCESSED
Friday, April 4, 2025NEW REPRESENTATIVE AT IB RECEIVED
Saturday, December 7, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, November 17, 2024FINAL DISPOSITION NOTICE SENT TO IB